Abstract
Incomplete struts coverage is a predictor of late stent thrombosis after implantation of the drug-eluting stents (DES) in atherosclerotic lesions. The process of struts coverage in DES implanted for bare-metal stent (BMS) restenosis has never been described. Thirty-two patients with stable coronary artery disease were consecutively selected, 11 with BMS restenosis (group A) and 21 with de novo atherosclerotic lesions (group B). All patients underwent everolimus-eluting stent implantation; coronary angiography and optical coherence tomography were performed at 6 months follow-up. Percentage difference in struts coverage between the 2 groups was the primary end point. A total of 85,773 struts (17,891 in group A and 67,882 in group B) were analyzed: compared with group B, the percentage of uncovered stent struts was significantly lower in group A (2.6% vs 4.8%; p <0.0001). In group A, DES struts protruding out of BMS were more uncovered (5.0% vs 1.9%; p <0.0001) and malapposed (4.1% vs 2.1%; p <0.0001) compared with overlapping struts. In conclusion, when DES are implanted to treat BMS restenosis, struts coverage at 6 months follow-up is more complete compared with DES implanted in atherosclerotic lesions.
References
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
May 4, 2005·Circulation·Marco A Costa, Daniel I Simon
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Dec 1, 2006·European Heart Journal·Daisuke MatsumotoMitsuhiro Yokoyama
Feb 27, 2007·Lancet·Joost DaemenPatrick W Serruys
Apr 18, 2007·Circulation·Aloke V FinnRenu Virmani
Sep 28, 2007·The American Journal of Cardiology·William S Weintraub
Jun 19, 2009·Heart·J-S KimY Jang
Nov 7, 2009·European Heart Journal·Francesco PratiUNKNOWN Expert's OCT Review Document
May 22, 2010·JACC. Cardiovascular Interventions·Giulio GuagliumiUNKNOWN ODESSA Trial Investigators
Oct 16, 2010·Journal of the American College of Cardiology·David R HolmesDavid J Moliterno
Nov 6, 2010·Heart·Takumi InoueKen-Ichi Hirata
Sep 14, 2011·Circulation·Ajay J Kirtane, Gregg W Stone
Mar 23, 2012·Circulation·Marco ValgimigliUNKNOWN Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators
Apr 24, 2012·American Heart Journal·Jung-Sun KimYangsoo Jang
Jun 2, 2012·European Heart Journal·Francesco PratiUNKNOWN Expert's OCT Review Document
Mar 26, 2013·JACC. Cardiovascular Interventions·Ajay J KirtaneUNKNOWN ENDEAVOR IV Investigators
Jul 3, 2013·American Heart Journal·Juan Luis Gutiérrez-ChicoPatrick W Serruys
Aug 30, 2013·The New England Journal of Medicine·Peter Libby
Citations
Feb 8, 2016·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Rui Cruz FerreiraMarco Costa
Jun 1, 2016·Molecular Pharmaceutics·Daniel G GliescheHenriette E Meyer Zu Schwabedissen
Jan 7, 2017·World Journal of Transplantation·Aparna Dalal
Jul 9, 2017·Heart and Vessels·Naoto TamaHiroshi Tada